In June this year, Paul Henderson received test results showing elevated PSA levels. In this weekly diary, he will be sharing ...

Royal Philips recently announced FDA 510(k) clearance of the latest version of the company’s UroNav system for image-guided ...

Michael, David, Paul – the names of just three of our readers who have had to take matters into their own hands when it comes ...

A new study reveals that some men who are diagnosed with “Grade Group one” (GG1) prostate cancer may actually be at higher ...

The team included and monitored nearly 600 patients with suspected prostate cancer in their study. The subjects underwent multiparametric magnetic resonance imaging (mpMRI) at Charité.

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical trials. A team at Heriot-Watt University, Edinburgh, leading the ...

Prostate cancer, a growing concern worldwide, often progresses silently, making early detection crucial. Symptoms like ...

In the past, having metastatic castrate-resistant prostate cancer was like a death sentence with clinician not having much ...

PSMA-PET imaging uses tiny amounts of radioactive “tracers,” called radiotracers, that binds to prostate cancer cells, making them visible on PET scans.

In recent years, PSMA-PET imaging has become established as the standard of care for staging and identifying biochemical recurrence of prostate cancer 6. However, only a relatively small fraction ...

Source Reference: Holzgreve A, et al "PSMA-PET/CT findings in patients with high-risk biochemically recurrent prostate cancer with no metastatic disease by conventional imaging" JAMA Netw Open ...

Provided by PR NewswireJun 18, 2025, 12:00:00 PM Blue Earth Diagnostics Reinforces Leadership in Prostate Cancer Imaging and Highlights Expanding Pipeline at Society of Nuclear Medicine and ...